Clinical trial
A Phase IIb Dose Escalation Study of Levetiracetam for the Treatment of Neonatal Seizures
NCT05610085 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IIb Dose Escalation Study of Levetiracetam for the Treatment of Neonatal Seizures
- Lead sponsor
- University of California, San Diego
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- March 24, 2023
- Completion date
- December 31, 2027
- Enrollment
- 133 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
hypoxic-ischemic encephalopathy, neonatal encephalopathy, neonatal seizure, seizure newborn